Novel T-cell therapies may be able to achieve long-lasting remission and complete tumor regression in patients with advanced epithelial cancers, as was shown in 2 human papillomavirus (HPV)-related studies shared at the
Novel T Cell Therapies Yield Decade-Long Remission in Epithelial Cancer
